Is a complete KLSE/LACMED research report available?

No complete published report is available for klse/LACMED (KLSE/LACMED) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

klse/LACMED stock profile: metrics, valuation and analysis

Market cap	312M
Revenue (ttm)	181.7M
Net income (ttm)	18.2M
EPS (ttm)	MYR 0.16
Shares out	400M
P/E (trailing)	5.0x
P/E (forward)	11.1x
Volume	98,200

All KLSE/LACMED indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

MYR

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Malaysia
Country code	MY
Employees	100
Employees Change	16%
Employees Change Percent	19.05
Enterprise value	MYR 282.8M
Exchange	Bursa Malaysia
Financial currency	MYR
First seen	2026-05-10
Industry	Medical, Dental, and Hospital Equipment and Supplies
Last refreshed	2026-09-05
Market cap	MYR 312M
Price	MYR 0.78
Price currency	MYR
Rev Per Employee	1,816,670.82x
Sic	5047
Symbol	klse/LACMED
Website	https://www.lacmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.84%
EV Earnings	15.53x
EV/EBIT	11.49x
EV/EBITDA	10.38x
EV/Sales	1.56x
FCF yield	-10.98%
Forward P/E	11.14x
P/B ratio	2.55x
P/E ratio	5x
P/S ratio	1.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.55%
EBITDA Margin	14.89%
Gross margin	27.73%
Gross Profit	MYR 50.4M
Gross Profit Growth	1.18%
Gross Profit Growth Q	-9.79%
Net Income	MYR 18.2M
Net Income Growth	-4.84%
Net Income Growth Q	4.55%
Net Income Growth Qo Q	410.86%
Pretax Margin	13.85%
Profit Margin	10.02%
Profit Per Employee	MYR 182,081
ROA	8.88
ROCE	19.15
ROE	20.69
ROIC	20.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	63.84
EPS Growth Q	4.5
EPS Growth Qo Q	410.9
Revenue Growth	-4.08x
Revenue Growth Q	-3.96x
Revenue Growth Qo Q	55.27x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	MYR 1.05
Assets	MYR 228.5M
Cash	MYR 69M
Current Assets	MYR 211.6M
Current Liabilities	MYR 99.9M
Debt	MYR 39.8M
Debt EBITDA	MYR 1.46
Debt Equity	MYR 0.32
Debt FCF	MYR -1.16
Equity	MYR 122.5M
Interest Coverage	21.37
Liabilities	MYR 106M
Long Term Assets	MYR 16.9M
Long Term Liabilities	MYR 6.1M
Net Cash	MYR 29.2M
Net Cash By Market Cap	MYR 9.36
Net Cash Growth	115.13%
Net Debt EBITDA	MYR -1.08
Net Debt Equity	MYR -0.24
Tangible Book Value	MYR 120M
Tangible Book Value Per Share	MYR 0.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.12
Inventory Turnover	4.93
Net Working Capital	MYR 76.5M
Quick ratio	1.8
Working Capital	MYR 111.7M
Working Capital Turnover	MYR 2.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	41.96%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	MYR 0.01
Dividend Years	1
Dividend Yield	0.85%
Ex Div Date	2026-05-26
Last Dividend	MYR 0.01
Payout Ratio	41.74%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	0.76
All Time High	1.34
All Time High Change	-40.3%
All Time High Date	2026-01-12
All Time Low	0.65
All Time Low Change	23.08%
All Time Low Date	2026-06-15
ATR	0.03
Beta1y	0.32
Ch YTD	-10.11
High	0.81
High52	1.34
High52 Date	2026-01-12
High52ch	-41.79%
Low	0.78
Low52	0.65
Low52 Date	2026-07-30
Low52ch	20%
Ma50ch	5.93%
RSI	56.23
RSI Monthly	0
RSI Weekly	52.59
Sharpe ratio	0.35x
Sortino ratio	0.69
Total Return	42.81%
Tr YTD	-9.38
Tr1m	9.59%
Tr1w	8.84%
Tr3m	2.56%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	88,190,700%
Net Borrowing	23,757,122
Shares Insiders	77.08%
Shares Institutions	9.88%
Shares Out	400,000,000
Shares Qo Q	0%
Shares Yo Y	-41.96%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	794,925x
Bv Per Share	0.31
CAPEX	MYR -10.5M
Ch1m	9.59
Ch1w	8.84
Ch3m	2.56
Ch6m	-13.51
Change	-2.5%
Change From Open	-2.5
Close	0.8
Days Gap	0
Depreciation Amortization	2,429,788
Dollar Volume	76,596
Earnings Date	2026-11-19
EBIT	MYR 24.6M
EBITDA	MYR 27M
EPS	MYR 0.16
F Score	5
FCF	MYR -34.3M
FCF EV Yield	-12.12x
FCF Per Share	MYR -0.09
Financing CF	67,987,493
Fiscal Year End	December
Founded	2,003
Graham Number	1.03684
Graham Upside	29.6
Income Tax	MYR 7M
Investing CF	-5,359,613
Is Primary Listing	1
Last Report Date	2026-06-30
Ma150	0.83
Ma150ch	-3.86%
Ma20	0.8
Ma20ch	0.19%
Net CF	38,762,974
Next Earnings Date	2026-11-19
Open	0.8
Payment Date	2026-06-15
Position In Range	16.67
Ppne	11,747,000
Price Date	2026-09-04
Price EBITDA	MYR 11.53
Ptbv Ratio	2.6
Relative Volume	0.12x
Revenue	181,667,082x
Tax By Revenue	3.87x
Tax Rate	27.95%
Tr6m	-12.81%
Volume	98,200
Z Score	4.17

KLSE/LACMED (KLSE/LACMED)

Price

Financial snapshot

Fair-value bridge

Latest news · KLSE/LACMED

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KLSE/LACMED indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on KLSE/LACMED

Frequently asked questions